|Podcasts|February 14, 2019
Episode 25: China’s Pharma Growth
Author(s)Michelle Maskaly, Christen Harm
Michelle Maskaly and Christen Harm talk with David Shao, CEO of Yisheng Biopharma, about what’s driving China’s exploding pharma and biotech industries, as well as the country’s push to become a global life science leader.
Advertisement
Michelle Maskaly and Christen Harm talk with David Shao, CEO of Yisheng Biopharma, about what’s driving China’s exploding pharma and biotech industries, as well as the country’s push to become a global life science leader.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
2
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
3
The New Healthy Aging Imperative and What It Means for Pharma
4
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
5